Skip to main content

An official website of the United States government

You have 2 new alerts

FY25 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science

General Information

  • Contract Opportunity Type: Special Notice (Updated)
  • Updated Published Date: Feb 26, 2025 09:49 am EST
  • Original Published Date: Oct 03, 2024 11:24 am EDT
  • Updated Response Date: Mar 04, 2025 11:59 pm EST
  • Original Response Date: Feb 24, 2025 11:59 pm EST
  • Inactive Policy: Manual
  • Updated Inactive Date: Sep 30, 2025
  • Original Inactive Date: Sep 30, 2025
  • Initiative:
    • None

Classification

  • Original Set Aside:
  • Product Service Code: AJ11 - GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
  • NAICS Code:
    • 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
  • Place of Performance:
    Silver Spring , MD 20993
    USA

Description

Amendment 05 - The BAA Notice has been updated to version 6 with various changes throughout.

Amendment 04 - The BAA Notice has been updated to version 5 with various changes throughout. Table 1 and attachment 5 have also been updated and included seperately. The response date has been changed to March 04th at 1159 PM EST.

Amendment 03 - The BAA Notice has been updated to version 4 with various changes throughout, Table 1 and attachments 4 and 5 have also been updated and included seperately. 

Amendment 02 - The BAA Notice has been updated to version 3 with various changes throughout.

Amendment 01 - The BAA Notice has been updated to version 2 with various changes throughout, and table 1 has been updated and included seperately. 

In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement. 

FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation. Join us to learn more about the FY 2025 BAA, and how to apply. 

Save the date for the 2024 FDA Broad Agency Announcement (BAA) Day! November 14th, 2024. BAA Day for  FY25 2024 will be hosted on November 14th, 2024, as a virtual only event and will provide an opportunity to learn more about the application process and FDA’s priorities for regulatory research.

https://www.fda.gov/science-research/advancing-regulatory-science/2024-fda-broad-agency-announcement-day-11142024

Contact Information

Contracting Office Address

  • 5630 Fishers Lane
  • Rockville , MD 20857
  • USA

Primary Point of Contact

Secondary Point of Contact





History